Eugene Schneider

CIK: 0001838539

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (45.5%)

Position reduction

Option Exercises (M)4 (18.2%)

Derivative conversions

Awards (A)8 (36.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IONS

IONIS PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (22 total)

IONS
IONIS PHARMACEUTICALS INC
Jun 26, 2026
Sale(S)
Direct
26K shares at avg. $81.05$2.1M
IONS
IONIS PHARMACEUTICALS INC
Jun 26, 2026
Exercise(M)
Direct
26K shares at avg. $60.89$1.6M
IONS
IONIS PHARMACEUTICALS INC
Mar 19, 2026
Sale(S)
Direct
5.8K shares at avg. $70.97$412K
IONS
IONIS PHARMACEUTICALS INC
Jan 30, 2026
Sale(S)
Direct
6.2K shares at avg. $83.45$516K
IONS
IONIS PHARMACEUTICALS INC
Jan 29, 2026
Award(A)
Direct
12K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 16, 2026
Sale(S)
Direct
9.3K shares at avg. $75.59$703K
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Performance Restricted Stock Units
Direct
25.8K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Award(A)
Restricted Stock Unit
Direct
9.7K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2026
Exercise(M)
Direct
21.7K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 2, 2026
Award(A)
Non-Qualified Stock Option (right to buy)
Direct
19.4K shares-
IONS
IONIS PHARMACEUTICALS INC
Sep 3, 2025
Exercise(M)
Direct
19.7K shares at avg. $53.77$1.1M
IONS
IONIS PHARMACEUTICALS INC
Sep 3, 2025
Sale(S)
Direct
12.5K shares at avg. $60.46$753K
IONS
IONIS PHARMACEUTICALS INC
Sep 3, 2025
Sale(S)
Direct
7.2K shares at avg. $61.42$442K
IONS
IONIS PHARMACEUTICALS INC
Aug 4, 2025
Sale(S)
Direct
9.5K shares at avg. $42.80$409K
IONS
IONIS PHARMACEUTICALS INC
Jan 31, 2025
Sale(S)
Direct
1.5K shares at avg. $32.20$48K
IONS
IONIS PHARMACEUTICALS INC
Jan 30, 2025
Award(A)
Direct
4K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 16, 2025
Sale(S)
Direct
6.5K shares at avg. $32.79$214K
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2025
Award(A)
Performance Restricted Stock Units
Direct
22K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2025
Award(A)
Restricted Stock Unit
Direct
33K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 15, 2025
Exercise(M)
Direct
17.4K shares-
IONS
IONIS PHARMACEUTICALS INC
Jan 2, 2025
Award(A)
Non-Qualified Stock Option (right to buy)
Direct
22K shares-
IONS
IONIS PHARMACEUTICALS INC
Feb 2, 2024
Sale(S)
Direct
2.1K shares at avg. $49.59$104K

		Type	Shares	Price		Ownership
Jun 26, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	26,000	$81.05	$2,107,196	Direct
Jun 26, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	26,000	$60.89	$1,583,140	Direct
Mar 19, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	5,812	$70.97	$412,486	Direct
Jan 30, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	6,179	$83.45	$515,630	Direct
Jan 29, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A)	11,991	-	$0	Direct
Jan 16, 2026	IONS IONIS PHARMACEUTICALS INC	Sale(S)	9,302	$75.59	$703,138	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Performance Restricted Stock Units	25,800	-	-	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Restricted Stock Unit	9,675	-	-	Direct
Jan 15, 2026	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	21,685	-	$0	Direct
Jan 2, 2026	IONS IONIS PHARMACEUTICALS INC	Award(A) Non-Qualified Stock Option (right to buy)	19,350	-	-	Direct
Sep 3, 2025	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	19,658	$53.77	$1,057,011	Direct
Sep 3, 2025	IONS IONIS PHARMACEUTICALS INC	Sale(S)	12,455	$60.46	$753,039	Direct
Sep 3, 2025	IONS IONIS PHARMACEUTICALS INC	Sale(S)	7,203	$61.42	$442,382	Direct
Aug 4, 2025	IONS IONIS PHARMACEUTICALS INC	Sale(S)	9,549	$42.80	$408,701	Direct
Jan 31, 2025	IONS IONIS PHARMACEUTICALS INC	Sale(S)	1,484	$32.20	$47,780	Direct
Jan 30, 2025	IONS IONIS PHARMACEUTICALS INC	Award(A)	4,032	-	-	Direct
Jan 16, 2025	IONS IONIS PHARMACEUTICALS INC	Sale(S)	6,523	$32.79	$213,889	Direct
Jan 15, 2025	IONS IONIS PHARMACEUTICALS INC	Award(A) Performance Restricted Stock Units	22,000	-	-	Direct
Jan 15, 2025	IONS IONIS PHARMACEUTICALS INC	Award(A) Restricted Stock Unit	33,000	-	-	Direct
Jan 15, 2025	IONS IONIS PHARMACEUTICALS INC	Exercise(M)	17,372	-	$0	Direct
Jan 2, 2025	IONS IONIS PHARMACEUTICALS INC	Award(A) Non-Qualified Stock Option (right to buy)	22,000	-	-	Direct
Feb 2, 2024	IONS IONIS PHARMACEUTICALS INC	Sale(S)	2,106	$49.59	$104,437	Direct

1-22 of 22 transactions

About Schneider Eugene

Schneider Eugene (SEC CIK 0001838539) files insider reports with the SEC as EVP, Chf Clinical Develop Ofcr of IONIS PHARMACEUTICALS INC (IONS).

Signal8 holds 11 ownership filings by Schneider Eugene, all Form 4s, filed between Sep 4, 2024 and Jun 30, 2026. Those filings report 22 transactions, from Feb 2, 2024 to Jun 26, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Schneider Eugene's filings is in CARLSBAD, CA.

Recent filings by Schneider Eugene

Jun 26, 2026: Open-market sale of IONS shares (Form 4, code S).
Jun 26, 2026: Option exercise of IONS shares (Form 4, code M).
Mar 19, 2026: Open-market sale of IONS shares (Form 4, code S).
Jan 30, 2026: Open-market sale of IONS shares (Form 4, code S).
Jan 29, 2026: Grant or award of IONS shares (Form 4, code A).

Other insiders filing for IONIS PHARMACEUTICALS INC (IONS)

Devers Shannon L., EVP, Chief Human Resources Ofc
Swayze Eric, EVP Research
BENNETT C FRANK, EVP, Chief Scientific Officer
O'NEIL PATRICK R., EVP CLO & General Counsel
Monia Brett P, Chief Executive Officer
Birchler Brian, EVP, Corp and Development Ops

How to read Form 4 transaction codes